2024

• Lee, Oukseub; Bazzi, Latifa A.; Xu, Yanfei et al. (2024). A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects. (external link)
• Kaur, Jaspreet; Jung, Sung Yun; Austdal, Marie et al. (2024). Quantitative proteomics reveals serum proteome alterations during metastatic disease progression in breast cancer patients. (external link)
• Mc Laughlin, Anna M.; Helland, Thomas; Klima, Fenja et al. (2024). Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort. (external link)
• Mellgren, Gunnar; Helland, Thomas; Jonsdottir, Kristin et al. (2024). Håvard Søiland. (external link)

2023

• Khan, Seema A.; Mi, Xinlei; Xu, Yanfei et al. (2023). Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women with Ductal Carcinoma in Situ: A Randomized Clinical Trial. (external link)
• Eliassen, Finn; Blåfjelldal, Vibeke Iren Jensen; Helland, Thomas et al. (2023). Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review. (external link)

2022

• Søiland, Håvard; Janssen, Emiel; Helland, Thomas et al. (2022). Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study. (external link)

2021

• Chen, Yuanhuang; Marcath, Lauren A.; Eliassen, Finn Magnus et al. (2021). Effect of genetic variability in 20 pharmacogenes on concentrations of tamoxifen and its metabolites. (external link)
• Helland, Thomas; Alsomairy, Sarah; Lin, Chenchia et al. (2021). Generating a precision endoxifen prediction algorithm to advance personalized tamoxifen treatment in patients with breast cancer. (external link)
• DeCensi, Andrea; Johansson, Harriet; Helland, Thomas et al. (2021). Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial. (external link)

See a complete overview of publications in Cristin.